Brian G. Mitchell, PharmD, BCPS, BCPP | Psychiatrist.com

Caffeine Reduction Increases Serum Lithium Concentration

Case Report

Caffeine Reduction Increases Serum Lithium Concentration

April 11, 2024

A patient with schizoaffective disorder was found to have supratherapeutic lithium serum concentrations following sudden caffeine reduction, and management with lithium dosage reduction precipitated exacerbation of psychiatric symptomatology.

Jeffrey J. Song, Jorgen C. Eyabi, Poonam D. Awatramani, et al

History of Suicide Attempt and Clozapine in Veterans With Schizophrenia

Original Research

History of Suicide Attempt and Clozapine in Veterans With Schizophrenia

November 1, 2022

This study evaluated whether a history of suicide attempt increases the odds of receiving clozapine treatment in veterans with schizophrenia or schizoaffective disorder.

Gregory H. Jones, Brian G. Mitchell, Jared Bernard, et al

Brief Report

Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia

August 24, 2021

Does clozapine treatment increase the odds of testing positive for COVID-19? This small study of a VA patient population posed the question.

Olaoluwa O. Okusaga, Brian G. Mitchell, Jared D. Bernard, et al

Letter to the Editor

Neuroleptic Malignant Syndrome and Risperidone

November 30, 2017

Neuroleptic malignant syndrome is a severe idiosyncratic and potentially life-threatening adverse effect of antipsychotic therapy characterized by fever, rigidity, altered mental status, creatine kinase elevation, and autonomic instability. Here,...

Brian G. Mitchell, Brady C. McMahon, Candice W. Mitchell

Letter to the Editor

Psychotic Exacerbation Following Subcutaneous Leuprolide

April 6, 2017

Could leuprolide therapy cause a worsening of psychosis after an extended period of psychiatric stability? Here, read about a man with prior history of paranoid schizophrenia who experienced an...

Brian G. Mitchell, Ashley L. Adams, Poonam K. Thandi